Search Thermo Fisher Scientific
- Contáctenos
- Orden Rápida
-
¿No tiene una cuenta? Crear una cuenta
Search Thermo Fisher Scientific
Why are complex diseases difficult to predict? Many diseases and disorders are considered “complex” because they do not follow a predictive pattern of inheritance. These complex diseases are also sometimes referred to as multifactorial diseases, which means they are a result of a combination of multiple factors that contribute to the condition.
Not all of these factors are well understood. For example, some conditions like Alzheimer’s disease, hypertension or diabetes may have a genetic component that puts someone at a higher risk, but a subset of those individuals never develop the condition.
In addition to genetics, other contributing factors that influence a complex disease may be the environment, lifestyle and the interaction of these factors (Figure 1).
Complex diseases and disorders are typically categorized into the following:
Many genetic analysis solutions are limited to providing genetic information about a given disease. Because complex diseases are influenced by more than genetics, multiple technologies are often required to uncover additional information about the environmental and lifestyle causes.
With targeted NGS, one technology can help you research genetics and beyond:
Ion Torrent focused next-generation sequencing technology is a simple and scalable way to approach complex disease research. Our streamlined sample-to-answer workflow offers multi-dimensional analysis and makes it easy for any lab to bring NGS in house, regardless of your team’s current level of NGS expertise.
Whether you are performing targeted exome sequencing or studying the immune repertoire, our comprehensive solutions enable you to study multiple components of complex disease on a single NGS system.
Easily adopt targeted NGS for your lab:
Go from DNA to data in less than 24 hours with ~45 minutes of hands-on time
Streamlined solution with complete informatics suite for accurate, multi-dimensional analysis to study the immune system’s role in complex diseases like rheumatoid arthritis and multiple sclerosis. Obtain deeper insights into the adaptive immune system with targeted NGS:
Enabling NGS analysis and discovery of multi-biomarker types (fusions, insertion/deletions (indels), single nucleotide variants (SNV), and copy number variations(CNV)). The Oncomine assays are part of a streamlined end-to-end workflow that includes simple, scalable sequencing with a comprehensive informatics and reporting suite—designed for cancer research.
Scalable targeted NGS to support small and large projects
The Ion GeneStudio S5 system is a scalable, targeted-NGS workhorse with wide application breadth and throughput capability.
Specimen to report in a single day with a hands-off, automated workflow*
The Genexus System is the first turnkey NGS solution that automates the specimen-to-report workflow and delivers results in a single day with just two user touchpoints.*